Sponsored by:

Video from ECR 2015: Thomas Beyer, PhD, on hybrid imaging

Mar 5, 2015
Latest in Nuclear Medicine
Biodistribution of Lu-177 AKIR001. (A) Mice (N = 12) bearing BxPC3 tumors were injected with Lu-177 AKIR001 and dissected at 24 (N = 4), 96 (N = 4), and 168 hours (N = 4) postinjection. Error bars represent SD. (B) Representative SPECT/CT images at 96 hours postinjection. GI = gastrointestinal.
SNMMI highlights new radiopharmaceutical therapy
May 13, 2026
Molecular Imaging News Platform: trends, insights, professional views.
Sponsored
Molecular Imaging News Platform: trends, insights, professional views.
April 14, 2026
Fda Button 400
C-Ray Therapeutics wins FDA active status for Cu-64 drug master file
April 28, 2026
A Rk Nx1 Fop15 Je H Jffj8rq D13
TAG1, NRG Pallas to advance Pb-212 supply for cancer therapies
April 22, 2026
Related Stories
2015 02 26 13 13 14 983 2015 03 04 Ecr Today Antoch Esophageal Cancer Post Therapy 20150226201338
Nuclear Medicine
Hybrid techniques make giant strides in clinical practice
2015 02 19 17 31 35 343 Petct Fifth Image Jnm 200
Nuclear Medicine
Multiple FDG-PET/CT scans can influence lung cancer treatment
2015 02 12 17 29 35 546 Pet Amyvid Thumbnail 200
Nuclear Medicine
U.S. SPECT, PET radiopharma market shows promise amid challenges
Molecular Imaging News Platform: trends, insights, professional views.
Sponsor Content
Molecular Imaging News Platform: trends, insights, professional views.
More in Nuclear Medicine
SNMMI highlights new radiopharmaceutical therapy
By AuntMinnie.com staff writers
Mice bearing PDAC xenografts received lutetium-177 (Lu-177) AKIR001, a radiopharmaceutical that targets CD44v6.
May 13, 2026
Biodistribution of Lu-177 AKIR001. (A) Mice (N = 12) bearing BxPC3 tumors were injected with Lu-177 AKIR001 and dissected at 24 (N = 4), 96 (N = 4), and 168 hours (N = 4) postinjection. Error bars represent SD. (B) Representative SPECT/CT images at 96 hours postinjection. GI = gastrointestinal.
Eden Radioisotopes files NRC permit for isotope production complex
By AuntMinnie.com staff writers
The company said the facility is designed to produce up to 50% of global demand for molybdenum-99 (Mo-99).
May 6, 2026
Isotopes
C-Ray Therapeutics wins FDA active status for Cu-64 drug master file
By AuntMinnie.com staff writers
C-Ray Therapeutics has received active status from the FDA for its Type II Drug Master File for Cu-64 chloride for radiolabeling.
April 28, 2026
Fda Button 400
TAG1, NRG Pallas to advance Pb-212 supply for cancer therapies
By AuntMinnie.com staff writers
TAG1 and NRG Pallas aim to develop access to lead-212 (Pb-212) for cancer drug development across Europe.
April 22, 2026
A Rk Nx1 Fop15 Je H Jffj8rq D13
Ionetix raises $30M to scale radioisotope production
By AuntMinnie.com staff writers
The funding will support scaling up of radioisotope production as well as R&D efforts in nuclear energy, materials testing, and related areas.
April 21, 2026
Isotopes1
Telix doses first patient in glioblastoma trial
By AuntMinnie.com staff writers
The patient was dosed at Austin Health in Melbourne, Australia.
April 15, 2026
A Ibrain
Shine receives $263M conditional loan for Mo-99 isotope facility
By AuntMinnie.com staff writers
Shine has received a conditional loan from the U.S. DOE to complete the Chrysalis medical isotope production facility for Mo-99.
April 9, 2026
Chrysalis, Shine’s large-scale irradiation facility, will complement the existing supply chain with the goal of ensuring a sustainable and reliable source of isotopes, including Mo-99.
First patients treated in RYZ401 radiopharmaceutical trial
By AuntMinnie.com staff writers
RYZ401 is an investigational actinium-225 (AC-225)-based radiopharmaceutical targeting somatostatin receptors in neuroendocrine tumors.
April 8, 2026
Atom Molecule
Consortium launches 5-year plan to improve theranostics outcomes
By Will Morton
The project aims to pave the way for personalized radiopharmaceutical therapy.
April 6, 2026
Isotopes1
SpectronRx raises $85M to expand radiopharmaceutical production
By AuntMinnie.com staff writers
The funding will support infrastructure investment at the company's Grissom Aeroplex campus in Indiana.
April 2, 2026
Cash
Cardinal Health expands Ac-225 production
By AuntMinnie.com staff writers
Since launching routine Ac-225 production at scale in late 2024, the company said it has quadrupled its weekly output.
April 1, 2026
Isotopes1
Radiopharmaceutical Therapy Tracker
With so many targeted diagnostic and therapeutic radiopharmaceuticals in development for cancer care, AuntMinnie's new pipeline update tool can help keep track.
March 30, 2026
Rt Tracker
Page 1 of 442
Next Page